COO
The Cooper Companies, Inc.
64.42
8 x 64.37
8 x 64.48
bid
ask
-
0.53
0.82%
8 @ 04:00 PM
65.00 +0.58 (0.90%)
Ytd -21.40%
1y -21.99%
63.72
day range
64.80
64.32
52 week range
84.44
Open 64.73 Prev Close 64.95 Low 63.72 High 64.80 Mkt Cap 12.57B
Vol 2.16M Avg Vol 1.96M EPS 1.99 P/E 32.37 Forward P/E 12.94
Beta 1.07 Short Ratio 3.19 Inst. Own 105.92% Dividend N/A Div Yield N/A
Ex Div Date 07-26 Earning 05-28 50-d Avg 74.74 200-d Avg 74.50 1yr Est 91.07
Earning
Date For Estimate Reported Surprise surprise %
2026-06-04 2026-04 1.1 N/A N/A N/A
2026-03-05 2026-01 1.03 1.1 0.07 6.80%
2025-12-04 2025-10 1.11 1.15 0.04 3.60%
2025-08-27 2025-07 1.07 1.1 0.03 2.80%
2025-05-29 2025-04 0.93 0.96 0.03 3.23%
2025-03-06 2025-01 0.92 0.92 N/A N/A
Upgrade / Downgrade
Date Firm Action From To
2026-03-06 Citigroup Upgrade Neutral Neutral
2026-03-06 Barclays Upgrade Overweight Overweight
2026-03-06 Needham Upgrade Buy Buy
2026-02-03 Needham Upgrade Buy Buy
2026-01-26 Barclays Upgrade Overweight Overweight
2025-12-08 Citigroup Upgrade Neutral Neutral
Profile
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Insider Holder
Date Name Relation Quantity Description
2026-01-07 ANDREWS BRIAN G Chief Financial Officer 30.73K Conversion of Exercise of derivative security
2026-03-31 JAY COLLEEN E Director 39.91K Conversion of Exercise of derivative security
2025-03-31 KOZY WILLIAM A Director 31.15K Conversion of Exercise of derivative security
2026-03-31 MADDEN TERESA SMITH Director 15.68K Conversion of Exercise of derivative security
2026-01-07 MCBRIDE DANIEL G Chief Operating Officer 163.85K Conversion of Exercise of derivative security
2026-03-31 RIVAS MARIA Director 14.46K Conversion of Exercise of derivative security
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Vanguard Group Inc 23.55M 1.52B 12.07%
2025-12-30 Blackrock Inc. 16.49M 1.06B 8.45%
2025-12-30 Capital World Investors 10.21M 657.61M 5.23%
2025-12-30 T. Rowe Price Investment Management, Inc. 9.05M 582.82M 4.64%
2025-12-30 State Street Corporation 8.79M 566.49M 4.51%
2025-12-30 Kayne Anderson Rudnick Investment Management LLC 7.20M 463.75M 3.69%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 6.23M 401.02M 3.19%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 5.01M 322.84M 2.57%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund 4.51M 290.63M 2.31%
2025-12-30 T. Rowe Price Mid-Cap Growth Fund, Inc. 4.27M 275.32M 2.19%
2026-03-30 NEW PERSPECTIVE FUND 3.61M 232.38M 1.85%
2025-12-30 T. Rowe Price Mid-Cap Value Fund, Inc. 3.18M 204.68M 1.63%
Dividend
Dividend Date
0.03 2023-07-27
0.03 2023-07-26
0.03 2023-01-20
0.03 2022-07-26
0.03 2022-01-20
0.03 2021-07-26
Split
Split Date
4 : 1 2024-02-20
2 : 1 2002-11-25
1 : 3 1995-09-22
110 : 100 1983-09-26